For the most up-to-date news and information about the coronavirus pandemic, visit the WHO website.
Moderna will apply to the US Food and Drug Administration (FDA) to authorize its coronavirus vaccine for emergency use, the drug company said Monday. Its data shows that the vaccine is 94.1% effective against COVID-19, similar to results it reported earlier this month.
The first injections may come as soon as Dec. 21 if the FDA gives its approval, the bioreports reported Moderna CEO Stéphane Bancel as saying.
For more like this
Subscribe to the Bioreports Now newsletter for our editors’ picks of the most important stories of the day.
It’s the second company to apply for emergency use authorization — Pfizer submitted its application for its vaccine on Nov. 20, the Times noted.